The following pages link to Mirjam Moerbeek (Q435013):
Displaying 15 items.
- Cost-effective designs for trials with discrete-time survival endpoints (Q435014) (← links)
- (Q957156) (redirect page) (← links)
- Robustness properties of \(A\)-,\(D\)-, and \(E\)-optimal designs for polynomial growth models with autocorrelated errors (Q957157) (← links)
- A comparison of estimation methods for multilevel logistic models (Q1424625) (← links)
- The influence of a covariate on optimal designs in longitudinal studies with discrete-time survival endpoints (Q1623493) (← links)
- Optimal treatment allocation and study duration for trials with discrete-time survival endpoints (Q1937208) (← links)
- OPTIMAL EXPERIMENTAL DESIGNS FOR MULTILEVEL MODELS WITH COVARIATES (Q4540576) (← links)
- Optimal Experimental Designs for Multilevel Logistic Models with Two Binary Predictors (Q4681072) (← links)
- Power Analysis for Cluster Randomized Trials with Continuous Coprimary Endpoints (Q6055882) (← links)
- D‐optimal designs for a continuous predictor in longitudinal trials with discrete‐time survival endpoints (Q6063617) (← links)
- A multilevel structural equation model for assessing a drug effect on a patient‐reported outcome measure in on‐demand medication data (Q6068297) (← links)
- Optimal number of accrual groups and accrual group sizes in longitudinal trials with discrete-time survival endpoints (Q6552780) (← links)
- A comparison of the multilevel MIMIC model to the multilevel regression and mixed ANOVA model for the estimation and testing of a cross-level interaction effect: a simulation study (Q6563665) (← links)
- What are the statistical implications of treatment non-compliance in cluster randomized trials: a simulation study (Q6627226) (← links)
- Contamination: how much can an individually randomized trial tolerate? (Q6628117) (← links)
